News summarySeeking AlphaNov 3, 2026, 02:29 AM
Syndax anticipates Revuforj could exceed $2B in U.S. peak annual net revenue as post-transplant maintenance builds
earningscorporate_earnings
The supplied management outlook says Syndax is moving decisively toward profitability, but gives no Revuforj peak-revenue estimate. [[fact:fact-s4y3l0wpd]] That profitability outlook is classified as unconfirmed. [[fact:fact-s4y3l0wpd]] The available facts therefore do not substantiate the headline's U.S. peak-sales projection. [[fact:fact-s4y3l0wpd]]